Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 212957
Company: NAVINTA LLC
Company: NAVINTA LLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/20/2020 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
FOSAPREPITANT DIMEGLUMINE
POWDER;INTRAVENOUS; EQ 150MG BASE/VIAL
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
EMEND | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | Yes | AP | 022023 | MERCK AND CO INC |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 214616 | ASPIRO |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 211860 | BAXTER HLTHCARE CORP |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 212309 | BE PHARMS |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 212143 | CHIA TAI TIANQING |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 211160 | DR REDDYS |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 210625 | EUGIA PHARMA |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 206197 | FRESENIUS KABI USA |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 210689 | LUPIN LTD |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 209965 | MSN |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 204015 | MYLAN LABS LTD |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 212957 | NAVINTA LLC |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 214683 | PIRAMAL CRITICAL |
FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | EQ 150MG BASE/VIAL | POWDER;INTRAVENOUS | Prescription | No | AP | 213106 | QILU PHARM HAINAN |